GOLM1 and metabolic dysfunction-associated steatohepatitis: We thus evaluated the diagnostic performance of serum GP73 on hepatic necroinflammation in NASH patients, in parallel with ALT and GGT which are the most validated noninvasive indicators for hepatic necroinflammation in NASH patients [8].